133 related articles for article (PubMed ID: 10450922)
21. DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer.
Wang Y; Sun H; Xiao Z; Zhang G; Zhang D; Bao X; Li F; Wu S; Gao Y; Wei N
Cell Commun Signal; 2018 Sep; 16(1):52. PubMed ID: 30176902
[TBL] [Abstract][Full Text] [Related]
22. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
23. Reversal of mdr1-mediated multidrug resistance in human leukemia cells by a new spin-labeled derivative of podophyllotoxin.
Qi SN; Song LJ; Chen Y; Jing YX
Pharmazie; 2010 Feb; 65(2):117-21. PubMed ID: 20225656
[TBL] [Abstract][Full Text] [Related]
24. Buthionine sulphoximine-mediated sensitisation of etoposide-resistant human breast cancer MCF7 cells overexpressing the multidrug resistance-associated protein involves increased drug accumulation.
Schneider E; Yamazaki H; Sinha BK; Cowan KH
Br J Cancer; 1995 Apr; 71(4):738-43. PubMed ID: 7710938
[TBL] [Abstract][Full Text] [Related]
25. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptotic DNA fragmentation mediated by mitochondrial pathway with caspase-3-dependent BID cleavage in human gastric cancer cells by a new nitroxyl spin-labeled derivative of podophyllotoxin.
Yang YJ; Qi SN; Shi RY; Yao J; Wang LS; Yuan HQ; Jing YX
Biomed Pharmacother; 2017 Jun; 90():131-138. PubMed ID: 28347917
[TBL] [Abstract][Full Text] [Related]
27. Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma.
Lange B; Schroeder U; Huebener N; Jikai J; Wenkel J; Strandsby A; Wrasidlo W; Gaedicke G; Lode HN
Cancer Lett; 2003 Jul; 197(1-2):225-30. PubMed ID: 12880986
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the inhibitory effects of VP-16-213 (etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrlich ascites tumor cells in vitro.
Yalowich JC; Goldman ID
Cancer Res; 1984 Mar; 44(3):984-9. PubMed ID: 6692420
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of novel podophyllotoxin derivatives as potential antitumor agents.
Cheng WH; Cao B; Shang H; Niu C; Zhang LM; Zhang ZH; Tian DL; Zhang S; Chen H; Zou ZM
Eur J Med Chem; 2014 Oct; 85():498-507. PubMed ID: 25113878
[TBL] [Abstract][Full Text] [Related]
30. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein.
Doyle LA; Ross DD; Ordonez JV; Yang W; Gao Y; Tong Y; Belani CP; Gutheil JC
Br J Cancer; 1995 Sep; 72(3):535-42. PubMed ID: 7669558
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human lung cancer cells resistant to 4'-O-demethyl-4beta-(2"-nitro-4"-fluoroanilino)-4-desoxypodophyllotoxin , a unique compound in the epipodophyllotoxin antitumor class.
Tachibana Y; Zhu XK; Krishnan P; Lee KH; Bastow KF
Anticancer Drugs; 2000 Jan; 11(1):19-28. PubMed ID: 10757559
[TBL] [Abstract][Full Text] [Related]
32. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
Su GM; Davey MW; Davey RA
Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms.
Wang JZ; Tian X; Tsumura H; Shimura K; Ito H
Anticancer Drug Des; 1993 Jun; 8(3):193-202. PubMed ID: 8517913
[TBL] [Abstract][Full Text] [Related]
35. [p21(WAF1) transfection decreases sensitivity of K562 cells to VP-16].
Yang H; Wang SW; Yin HJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):31-4. PubMed ID: 12513833
[TBL] [Abstract][Full Text] [Related]
36. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
Gupta RS; Singh B
J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic responses to aromatic ring and configurational variations in alpha-conidendrin, podophyllotoxin, and sikkimotoxin derivatives.
Dantzig A; LaLonde RT; Ramdayal F; Shepard RL; Yanai K; Zhang M
J Med Chem; 2001 Jan; 44(2):180-5. PubMed ID: 11170627
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
39. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
